Avricore Health Inc. (AVCR.V)
CAD 0.05
(0.0%)
CAD 0.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 16.67% |
| 2022 | -0.01 CAD | 54.35% |
| 2021 | -0.02 CAD | 5.15% |
| 2020 | -0.02 CAD | 56.4% |
| 2019 | -0.04 CAD | 62.92% |
| 2018 | -0.12 CAD | 20.0% |
| 2017 | -0.15 CAD | 16.67% |
| 2016 | -0.18 CAD | 14.29% |
| 2015 | -0.21 CAD | -10.53% |
| 2014 | -0.19 CAD | -72.73% |
| 2013 | -0.11 CAD | -237.5% |
| 2012 | 0.08 CAD | 142.11% |
| 2011 | -0.19 CAD | 84.17% |
| 2010 | -1.20 CAD | 57.3% |
| 2009 | -2.81 CAD | -195.79% |
| 2008 | -0.95 CAD | 47.8% |
| 2007 | -1.82 CAD | -82.0% |
| 2006 | -1.00 CAD | -17.65% |
| 2005 | -0.85 CAD | 63.52% |
| 2004 | -2.33 CAD | 28.09% |
| 2003 | -3.24 CAD | -264.04% |
| 2002 | -0.89 CAD | 27.05% |
| 2001 | -1.22 CAD | -183.72% |
| 2000 | -0.43 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.54 CAD | -70.59% |
| 2024 Q1 | 0.00 CAD | 183.33% |
| 2023 FY | - CAD | 16.67% |
| 2023 Q2 | -0.00 CAD | -52.63% |
| 2023 Q3 | -0.00 CAD | 0.0% |
| 2023 Q4 | 0.00 CAD | 120.69% |
| 2023 Q1 | -0.00 CAD | 24.0% |
| 2022 Q1 | -0.00 CAD | 17.39% |
| 2022 Q2 | -0.00 CAD | -10.53% |
| 2022 Q3 | -0.00 CAD | 14.29% |
| 2022 Q4 | -0.00 CAD | -38.89% |
| 2022 FY | - CAD | 54.35% |
| 2021 Q3 | -0.00 CAD | -24.32% |
| 2021 FY | - CAD | 5.15% |
| 2021 Q1 | -0.01 CAD | 3.37% |
| 2021 Q2 | -0.00 CAD | 56.98% |
| 2021 Q4 | -0.00 CAD | 50.0% |
| 2020 FY | - CAD | 56.4% |
| 2020 Q2 | -0.00 CAD | 20.93% |
| 2020 Q1 | -0.00 CAD | 33.85% |
| 2020 Q4 | -0.01 CAD | -169.7% |
| 2020 Q3 | -0.00 CAD | 2.94% |
| 2019 Q1 | -0.01 CAD | 73.43% |
| 2019 FY | - CAD | 62.92% |
| 2019 Q4 | -0.01 CAD | 53.24% |
| 2019 Q3 | -0.01 CAD | -19.83% |
| 2019 Q2 | -0.01 CAD | 17.14% |
| 2018 FY | - CAD | 20.0% |
| 2018 Q4 | -0.05 CAD | -147.42% |
| 2018 Q3 | -0.02 CAD | 17.44% |
| 2018 Q2 | -0.03 CAD | -7.05% |
| 2018 Q1 | -0.02 CAD | 44.08% |
| 2017 Q2 | -0.03 CAD | 42.74% |
| 2017 FY | - CAD | 16.67% |
| 2017 Q4 | -0.04 CAD | -45.12% |
| 2017 Q3 | -0.03 CAD | -7.61% |
| 2017 Q1 | -0.05 CAD | 28.38% |
| 2016 FY | - CAD | 14.29% |
| 2016 Q1 | -0.05 CAD | -7.02% |
| 2016 Q3 | -0.02 CAD | 46.82% |
| 2016 Q2 | -0.04 CAD | 19.47% |
| 2016 Q4 | -0.07 CAD | -222.01% |
| 2015 Q4 | -0.05 CAD | -15.15% |
| 2015 Q1 | -0.04 CAD | 12.53% |
| 2015 Q2 | -0.09 CAD | -118.84% |
| 2015 Q3 | -0.04 CAD | 54.54% |
| 2015 FY | - CAD | -10.53% |
| 2014 Q2 | -0.03 CAD | 14.36% |
| 2014 FY | - CAD | -72.73% |
| 2014 Q3 | -0.02 CAD | 46.76% |
| 2014 Q4 | -0.05 CAD | -151.38% |
| 2014 Q1 | -0.04 CAD | -103.59% |
| 2013 FY | - CAD | -237.5% |
| 2013 Q4 | -0.02 CAD | 29.09% |
| 2013 Q3 | -0.03 CAD | 54.99% |
| 2013 Q1 | -0.01 CAD | -6.45% |
| 2013 Q2 | -0.06 CAD | -362.88% |
| 2012 Q4 | -0.01 CAD | -102.58% |
| 2012 FY | - CAD | 142.11% |
| 2012 Q1 | 0.04 CAD | 194.79% |
| 2012 Q2 | - CAD | -100.0% |
| 2012 Q3 | 0.48 CAD | 0.0% |
| 2011 Q3 | -0.12 CAD | 0.0% |
| 2011 FY | - CAD | 84.17% |
| 2011 Q1 | -0.16 CAD | 75.38% |
| 2011 Q2 | - CAD | 100.0% |
| 2011 Q4 | -0.04 CAD | 64.83% |
| 2010 FY | - CAD | 57.3% |
| 2010 Q1 | -1.22 CAD | -369.23% |
| 2010 Q2 | - CAD | 100.0% |
| 2010 Q4 | -0.65 CAD | -182.61% |
| 2010 Q3 | -0.23 CAD | 0.0% |
| 2009 FY | - CAD | -195.79% |
| 2009 Q4 | -0.26 CAD | 50.0% |
| 2009 Q3 | -0.52 CAD | 0.0% |
| 2009 Q2 | - CAD | 100.0% |
| 2009 Q1 | -0.18 CAD | 21.74% |
| 2008 Q4 | -0.23 CAD | 0.0% |
| 2008 Q1 | -0.28 CAD | 51.72% |
| 2008 Q2 | - CAD | 100.0% |
| 2008 Q3 | -0.23 CAD | 0.0% |
| 2008 FY | - CAD | 47.8% |
| 2007 Q1 | -0.15 CAD | 6.25% |
| 2007 Q2 | - CAD | 100.0% |
| 2007 FY | - CAD | -82.0% |
| 2007 Q4 | -0.58 CAD | -176.19% |
| 2007 Q3 | -0.21 CAD | 0.0% |
| 2006 Q4 | -0.16 CAD | 20.0% |
| 2006 FY | - CAD | -17.65% |
| 2006 Q2 | - CAD | 100.0% |
| 2006 Q1 | -0.24 CAD | 29.41% |
| 2006 Q3 | -0.20 CAD | 0.0% |
| 2005 Q4 | -0.34 CAD | -142.86% |
| 2005 Q3 | -0.14 CAD | 0.0% |
| 2005 Q1 | -0.40 CAD | 14.89% |
| 2005 FY | - CAD | 63.52% |
| 2005 Q2 | - CAD | 100.0% |
| 2004 Q3 | -0.44 CAD | 0.0% |
| 2004 Q2 | - CAD | 100.0% |
| 2004 Q1 | -0.60 CAD | 1.64% |
| 2004 FY | - CAD | 28.09% |
| 2004 Q4 | -0.47 CAD | -6.82% |
| 2003 FY | - CAD | -264.04% |
| 2003 Q2 | - CAD | 100.0% |
| 2003 Q1 | -0.19 CAD | 32.14% |
| 2003 Q4 | -0.61 CAD | -306.67% |
| 2003 Q3 | -0.15 CAD | 0.0% |
| 2002 FY | - CAD | 27.05% |
| 2002 Q4 | -0.28 CAD | -133.33% |
| 2002 Q3 | -0.12 CAD | 0.0% |
| 2001 FY | - CAD | -183.72% |
| 2000 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Telo Genomics Corp. | -0.04 CAD | 81.579% |